2019/06/28 08:11:03 | |
---|---|
Price | |
291.20 EUR | |
Difference | 0.10% (0.30) |
ISIN | CH0013841017 |
Symbol | LONN |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 38,954 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 291.20 EUR |
High | 291.20 EUR |
Low | 291.20 EUR |
Close (prev. day) | 290.90 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
Related Futures | 30 |
Related Options | - |
Date | Headline | Download | |
2024/10/29 | Global Equity Ratings | ||
2024/10/29 | Aktienempfehlungen Global | ||
2024/10/22 | Global Equity Ratings | ||
2024/10/22 | Aktienempfehlungen Global | ||
2024/10/14 | Aktienempfehlungen Österreich |
2019/06/28 08:11:03 | |
---|---|
Price | |
291.20 EUR | |
Difference | 0.10% (0.30) |
ISIN | CH0013841017 |
Symbol | LONN |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 38,954 EUR |
Benchmark | SWISS MARKET INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 291.20 EUR |
High | 291.20 EUR |
Low | 291.20 EUR |
Close (prev. day) | 290.90 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
6M | 1Y | 3Y | |
Perf (%) | +30.94% | +29.48% | +120.54% |
Perf (abs.) | +68.80 | +66.30 | +159.16 |
Beta | 0.93 | 1.11 | 1.36 |
Volatility | 30.25 | 29.47 | 26.05 |
Ø price 5 days | Ø volume 5 days (pcs.) | 293.04 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 287.62 EUR (1) |
Ø price 100 days | Ø volume 100 days (pcs.) | 270.74 EUR (3) |
Ø price 250 days | Ø volume 250 days (pcs.) | 267.04 EUR (2) |
YTD High | date | 302.60 EUR (2019/06/20) |
YTD Low | date | 221.90 EUR (2019/01/02) |
52 Weeks High | date | 302.60 EUR (2019/06/20) |
52 Weeks Low | date | 217.10 EUR (2018/12/27) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Singapore Exchange | 2011/10/21 | 09:51 | 74.0753 SGD | 0.00 | 1 |
SIX Swiss Exchange | 2024/11/01 | 12:09 | 544.60 CHF | 10.65 | 1,109 |
London Stock Exchange | 2024/10/31 | 11:58 | 535.40 CHF | 1.07 | 2 |
Hamburg | 2019/06/28 | 08:01 | 291.30 EUR | 0.00 | 2 |
Frankfurt | 2019/06/28 | 15:56 | 293.90 EUR | 0.02 | 4 |
FINRA other OTC Issues | 2024/10/31 | 20:58 | 604.60 USD | 0.08 | 6 |
Duesseldorf | 2019/06/28 | 08:11 | 291.20 EUR | 0.00 | 2 |
Berlin | 2019/06/28 | 18:45 | 296.90 EUR | 0.00 | 14 |
LONZA GROUP AG |
- - |
Muenchensteinerstrasse 38 - 4002 Basel |
Telefon: +41-61-316-81-11 |
Fax: +41-61-316-91-11 |
E-mail: media@lonza.com |
Lonza Group AG is engaged in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules segment offers small molecule drug substances and intermediates related services. The Cell and Gene segment includes the Cell and Gene Technologies and Bioscience businesses. The Capsule and Health Ingredients segment provides innovative capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies. The Corporate segment refers to finance and accounting, legal, communication, information technology, and human resources functions. The company was founded on October 27, 1897 and is headquartered in Basel, Switzerland. |
Wolfgang Wienand | Chairman of Managing Board |
Christian Seufert | Member of Executive Committee |
Daniel Palmacci | Member of Executive Committee |
Gordon Bates | Member of Executive Committee |
Jean-Christophe Hyvert | Member of Executive Committee |
Maria Soler Nunez | Member of Executive Committee |
Philippe Deecke | Member of Executive Committee |
Angelica Kohlmann | Member of the administrative board |
Marion Helmes | Member of the administrative board |
Olivier Verscheure | Member of the administrative board |
Roger Nitsch | Member of the administrative board |
Barbara Richmond | Member of the administrative board |
Christoph Mäder | Member of the administrative board |
Jürgen B. Steinemann | Member of the administrative board |
R. Jean-Marc Sidney Huët | Chairman of the administrative boar |
Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).
The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.
Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.
The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.
By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.